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Additive effects of dexamethasone and calcium on the calcitonin mRNA 
level in adrenalectomized rats 
Philippe Bemad*, VaGrie Jousset and Jam-Michel Garef 
Northern hybndrzabons were used to evaluate the &ects of dexamathasone and calcmm on calcttomn mRNA levels m adrenalectomzed female 
rats Two weeks after adrenalectomy, a 3 (i-fold decrease m the calcltonm mRNA level was observed (28% vs 1OOSg m sham-operated controls) 
After 5 days of dexamethasone treatment (1 5 mg/kg b wt), a 2 6-fold nse m calcltomn mRNA occurred m adrenalectomlzed rats (73% vs 28%) 
This increment was higher when dexamethasone treated animals were inJected with calcmm (100% vs 73%) The effect of calcmm on the calcltomn 
mRNA level of adrenalectonuzed ratstreated or not Hnth dexamethasone was smular, and additive m the former case Our data suggest hat calcmm 
aad dexamethasoae elevate calatomn mRNA by two d&erent mechamsms 
Messenger RNA, Calcstonm, Dexamethasone, G&mm, Adrenaiectomy, (Rat) 
Glucocorticoids are a major class of steroid hor- 
mones produced by the adrenal cortex and are impor- 
tant physiological regulators of gene expression. In 
severai target tissues includmg pituitary gland, liver, in- 
testine and adrenal medulla, they control the expression 
of a small number of genes by increasing or decreasing 
mRNA levels (for review, see [l]). In the thyroid, recent 
m vitro studies showed that DEX, a synthetic glucocor- 
ticoid, may change the mRNA concentration of CT, a 
Ca-lowering peptide hormone elaborated by the C- 
cells. In TT cells, a continuous human C-cell line deriv- 
ed from a medullary thyroid carcinoma, and in CA-77 
cells, a rat medullary thyroid carcinoma cell line, it has 
been reported that DEX enhanced the specific CT 
mRNA levels [2,3], but a decrease was observed in 44-2 
cells, another murine medullary thyroid carcinoma cell 
line 141. The basis of such differences in response to 
glucocorticoids remains unclear, although the proper- 
ties of the different transformed clonal cell strains used 
in these studies might explain these convicting data. 
Curiously, as yet, in vivo data are lacking. To deter- 
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mine If such a modulation of CT mRNA levels is pre- 
sent in the normal thyroid glands, ADX adult rats were 
injected for 5 days with DEX, and thyroid CT mRNAs 
were measured by Northern hybridization using a 
specific CT cDNA probe. Ca being the main CT 
secretagogue, an acute Ca injection was also performed 
in ADX and ADX + DEX rats to ascertain whether a 
glucocorticoid pretreatment potentiated the short-term 
response of C-cells to a Ca load. We report here that 
the marked drop in CT mRNA level occurring after 
ADX is partially compensated by the DEX treatment or 
a Ca load. These 2 stimuli have an additive effect on the 
CT mRNA level. No change in plasma CT level was 
observed 24 h after the last DEX injection, but the 
acute Ca load triggered a greater CT release in DEX- 
treated rats than in untreated ADX animals. This in 
vivo study suggests that the control of the CT gene ex- 
pression by glucocorticoids and Ca implies different 
mechanisms and that endogenous glucocorticoids may 
specificaliy enhance the thyroidal release of CT in 
response to h~erc~cemi~ stress in rats. 
2. MATERIALS AND METHODS 
2 1 AntmnIs artd trwtments 
Female Wlstar rats welghmg 242 f 3 g were purchased from CERJ 
(Le Genest, France). They were fed a commeraal du% (UAA AO3, 
Usme d’Ahmeatation Rationnelle, Vdlemorsson/Orge) contammg 
0 84% calcium, 0.78% phosphorus, 0.17% magnesium and 3QOOIU 
vltarnm D/kg. All surgery was performed under light ether 
anesthesta Adrenals were removed w&h fine-curved forceps. ADX 
females were mmntamed on 0 15 M NaCl m thetr drmkmg water 
Control rats were SO. One week after surgery, ammais were s c m- 
JeCted dally for 5 days llnth either 1.5 mg DEX (Serva, Heidelberg, 
~145793/89/~3 SO 0 1989 Federation of European Blochemrcal Soctetres 293 
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FRG),kg b.wt (ADX + DEX) or 15 /Lg DEX/kg b.wt (ADX + dex) 
and were killed 24 h after the last injection. Similarly, SO rats and 
a group of ADX females received the vehicle alone (100 pi absoiute 
ethanol). One hour before sacrifice, half of ADX and ADX + DEX 
groups were i.p, injected with 35 mg Ca as calcium giucono- 
~alactoglu~onate fC&cium SandozYkg b.wt giving the ADX + Ca 
and ADX f DEX -t Ca groups, respectively. Animals were killed by 
aortic puncture under light ether anesthesia. Thyroid glands were 
quickly removed and stored in liquid nitrogen until RNA extractions. 
2.2. Preporation of 32P-labeled probe 
The CT specific probe was the BgiII-Nsil fragment of the human 
CT cDNA. The plasmid containing near futl-length human CT cDNA 
was kindly provide by M.G. Rosenfefd ~Un~versity of California 
San Diego, La Jolla, CA 92093). component HLt-Blue cells 
(Stratagem?, La Jolla, GA 92037) were transformed by the pUC 8 
ptasmid. Recombinant ptasmids were seiected on ampicillin plates. 
Plasmid RNA was extracted by the akaline lysis method [S]. After 
enzymatic hydrolysis, the fragment BglII-&ssiI was electroeluted 
from the agarose gel, and labeled with i3’P]dCTP to a specific activi- 
ty of 5x 10’ cpm/hg by Nick-translation (Nick-translation kit, 
Amersham, England). 
A control probe was used to verify that equivalent amounts of 
RNAs were Ioaded. A 24-mer o~jgonu~I~~de specific of the rat f8S 
ribosomai RNA was 5’ end-labeled using T4 ~lynu~ieotide kinase 
and (r”P)ATP and then purified on Nensorb columns (NEN). 
Specific activity of 4.10’ cpm/Fg were achieved routinely. 
2.3. RNA extractions and Northern blot hybridizations 
RNAs were extracted from batches of 5 thyroid glands with 
~he~o~~hloroform and purified with LiCi pr~~pit~t~o~ [6] according 
to previously published procedures [7,8], Ahquots of 30 pg tot& 
RNAs were denatured by form~dehyde 191, and el~trophores~ on 
I % agarose gel ove~i~ht with 1 x MOPS buffer (I x MOPS: 0.02 
M mo~ho~jnoprop~e sulfonic acid, 0.005 M sodium acetate, 
0.001 M EDTA, pH 7.0). RNAs were transferred to gene-screen 
membranes (NEN) using 0.025 M sodium phosphate buffer pH 6.5. 
Membranes were dried and then baked for 2 h at SO’% For the CT 
probe membranes were prebybridized 4 h at 42GC in 50% for- 
mamide, 5 x SSC, 5 x Denhardt, 0.05 M sodium phosphate buffer 
pH 6.5, and fOOpg/ml of denaturated her&g sperm DNA. 
Hybridi~t~on was carried out in a modified prehybrid~zat~o~ buffer 
(i.e. i x Denhardt, 0.02 M sodium phosphate buffer, and 10% dex- 
tran sulfate) containing 10 ngimi of labeled human CT cDNA 
denatured by heating (lOO°C for IO mm). Membranes were washed 
by 2 changes of 2x SSC at room temperature for S min, and then 
2 changes of 2~ SSC, 1% SDS at 55°C for 30 mm, and finally 2 
changes of 0.1 x SSC at room temperature for JO min. For the 
ribosomal probe prehybridizat~on was carried out at 42V during 4 h 
in 5 x SSC, 0.1% Denhardt, 0.05 M sodium phosphate buffer pH 
6.5, 0.1% SDS, and 250 @g/m1 salmon sperm DNA. Hybri~zation 
was done overnight in the same solution in the presence of IO4 cpm 
of labeled OI~go~ucleotide. Membranes were washed 20 min in 2 x 
SSC at room temperature. Dried membranes were exposed at - 80°C 
to Kodak Royal X-Omat AA5 films. Autoradiographs were quan- 
tified in an automatic densitometric scanner (Shimadzu Scientific In- 
struments). 
2.4. Other methods 
Bfood samples were collected in polyethylene tubes cooted on ice 
water. After ~nt~fugatio~ at 4”C, ahquots of plasma were used im- 
mediately for calcium d~~minatjon by fhune photomet~ {Eppen- 
dorf, FCM 5341) and phosphorus analysis [lo], the remainder being 
frozen f - 35’Cf until CT was assayed. The CT in plasma was 
measured by a RIA which has been described in detail [ll]. The 
G 813 antibody (goat antiserum raised against synthetic human CT) 
was a gift of Dr H. Heath (Mayo Clinic and Mayo Foundation, 
Rochester, MN, USA). The detection limit of the assay was 40 pg/mi. 
All plasma samples were run in the same assay and intra-assay varia- 
tions were 5%. 
Results were expressed as means + SE. Significance of differences 
between groups was determined using Student’s_t est except for 
Northern results were all probabilities were calculated using the 
Mann-Whi~ey U-test for ranked non-par~etric data. 
3. RESULTS 
According to previous data [12), DEX-treated rats 
exhibited a 10% weight loss consecutively to the known 
catabolic effect of glucocorticoids on muscles, and a 
small decrease in food intake. The body weight loss was 
more important with high than low ~on~e~trations of 
DEX (220 t 2 g and 233 c 3 g, respectively vs 244 2 2g 
in ADX controls on day 5 of treatment; P< 0.001). By 
contrast, no difference was noted between ADX and 
SO groups (244 f 2 g vs 245 +- 2 g). 
As shown in fig.1 and in agreement with previous 
studies [ 12,131, plasma Ca fevels in ADX- and in DEX- 
treated rats were not different from values found in SO 
animals. Because a glu~ocorti~oid excess inhibits the Ca 
fixation in bones 1131, the same Ca Load yielded an in- 
crement in plasma Ca stronger in ADX + DEX than in 
ADX rats (18,02+0.25 vs 16.55+0.38 mgldt; 
P< 0.001). The plasma phosphorus concentrations 
were significantly lower in SO controls than in all other 
groups (fig. 1). 
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Fig-l. Effects of DEX and/or Ca treatments on plasma Ca and 
phosphate levels of ADX fernate rats. Mean + SE and the number of 
estimations. ***P<O.OOl compared to SO controls. ADX+DEX: 
1.5 mg DEXlkg b.wt/day for 5 days; ADX+dex: 15 cg DEX/kg 
b.wt./day during 5 days; ,f Ca: 35 mg Calkg b.wt 1 h before sacrifice, 
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Flg.2 Effects of DEX and/or Ca treatments on plasma CT levels of 
ADX female rats Mean+ SE, mdlvldual values were plotted 
***P<O 001 from SO controls For details, see legend of fig 1 
No difference m plasma CT concentrations were 
found in SO, ADX-, and DEX-treated rats (fig.2). The 
intraperitoneal injection of Ca induced respectively a 
3.5fold and a 6.4-fold increase in plasma CT levels in 
ADX + Ca and ADX + DEX + Ca groups, respectively, 
as compared to SO controls (0.52kO.02 and 
0.96 + 0.04 ng/ml vs 0.15 kO.01 ng/ml in SO; 
P<O.OOl). After DEX treatment, the Ca load induced 
a rise in plasma CT levels 1.8fold higher than m un- 
treated ADX rats. 
In order to determine whether ADX, DEX and Ca 
induced changes in CT gene expression, levels of 
thyroidal mRNA encoding for CT were determined by 
Northern hybridization. After densitometric scanning 
of autoradiograms, the CT mRNA level was expressed 
as the ratio of hybridizing signals between the CT probe 
and the 18s rRNA control probe (fig.3). A marked 
drop in CT mRNA occurred 2 weeks after ADX (fig.3). 
More than a 3.6-fold decrease was observed in ADX 
females as compared to SO controls (28% vs 100% m 
SO; mean values of 3 independent estimations; 
PcO.001). Five days of exposure to a high DEX con- 
centration yielded a 2.6-fold rise in thyroidal CT 
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Fig 3 Effects of DEX and/or Ca treatments on CT mRNA levels of 
thyroid glands from ADX female rats Two typical Northern blots 
are shown; each Northern blot represents RNAs extracted from 
groups of 5 animals In each case 30 cg of total RNAs were loaded 
The values indicate the RNA size m kb relative to h HIndI markers 
(A) Hybrldlzatlon with the CT speclflc probe (B) Hybrldlzatlon with 
a 18s rRNA probe to verify that equivalent amounts of RNAs were 
sampled (C) Bar graphs derived from densltometrlc scans of A/B 
ratios The results are given as percent of SO controls For details see 
legend of fig 1 
mRNA concentrations (73% vs 28% in ADX). In com- 
parison, a lOO-fold lower dose of DEX had no signifi- 
cant effect on CT mRNA levels. An acute Ca load 
induced a greater increment of the CT specific mRNA 
in DEX-treated ADX than in untreated ADX rats 
(100% and 49% respectively vs 28% in ADX controls). 
4. DISCUSSION 
These experiments were carried out to determine the 
effects of glucocorticords on the thyroidal CT mRNA 
level of the rat. We have used DEX rather than cor- 
ticosterone, the main natural glucocorticoid m rats, 
because this synthetic compound has an increased af- 
finity for glucocortrcotd receptors and a delayed 
plasma clearance which enhances tissue exposure. In 
addition, DEX has a negligible mineralocortrcoid effect 
and thus does not produce sodium retention, 
hypokaliemia, and hypertension. 
295 
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The dramatic fall m CT mRNA levels observed 2 
weeks after ADX was partrally compensated by the 
high DEX supply. This result might be explained in 2 
ways. Firstly, the glucocorticoid induces a selective 
growth of C-cells so that the observed effect IS strongly 
related to a shaft in glandular cell population. The fact 
that DEX markedly inhibits the C-cell growth in vitro 
[3,4] argues against this hypothesis. Furthermore, a 
great modification in the number of C-cells might be 
associated with detectable changes in plasma CT levels, 
an effect which does not occur here. Secondly, 
glucocorticoids are required for the maintenance of CT 
mRNA to the hrgh level which is known in the rat. In- 
deed, in this specres, the CT-secreting cells are very ac- 
tive since the mRNA coding for CT accounts for 3.8% 
of total mRNAs from the thyroids although the C-cells 
constitute less than 10% of total glandular cells [14]. 
This last hypothesis, which IS consistent with earlier m 
vitro studies [2,3], suggests a direct regulation of CT 
gene expression by endogenous glucocorticord hor- 
mones since DEX does not alter the stability of CT 
mRNA m the TT cell line [3]. 
Independently of the DEX effect, an increment m the 
specific CT mRNA concentration occurs 1 h after Ca 
mjection. This is the first time that a clear-cut effect of 
Ca on the hybridizable CT mRNA level 1s observed 
[ 15,161, The additive influence of DEX and Ca suggests 
a control of CT gene expression by two different ways 
for these 2 stimuli. Further studies wtll be required to 
determine whether glucoco~icoids and Ca increase the 
rate of transcrrptton and/or have an effect on the half- 
life of the messenger transcript. 
In vitro, DEX was reported to decrease [4] or to in- 
crease [17] the CT release by C-cell lines. In our ex- 
perimental conditions, no variation in plasma CT levels 
was observed after DEX treatment. According to 
Muszynski et al. [17], the acute secretory response to 
Ca was enhanced in DEX-treated females. For the same 
Ca load, plasma CT levels were 1 g-fold higher m DEX 
than m untreated ADX rats. The hypercalcemia trig- 
gered by the Ca injection does not alone explain such 
a CT release. These findings suggest hat DEX poten- 
tiates the Ca secretagogue ffect. Thus, the regulation 
of CT mRNA by DEX leads to an increase in the 
amount of CT m the plasma only following a hyper- 
calcemic stress. It is stxll unclear why, under basal con- 
ditions, there is no increase m plasma CT after DEX 
treatment. It IS possible that the extremely potent 
secretagogue ffect of Ca is necessary to reveal a con- 
comitant increase in plasma CT and cellular CT 
mRNA. 
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